API Manufacture
New Drug Development
Clinical Research
Pharmacy Services

Clinical Research Services

IDT provides clinical research services to multinational organisations throughout the world through our CMAX Division (Clinical, Medical, Analytical, Excellence).

www.cmax.com.au

We pride ourselves on completing projects on time and on budget. We deliver products and services of a high standard.

We provide our clients with a highly personalised service, building relationships with the client and the investigator, in order to maximise the value of the client’s study.

All phases of clinical trials are conducted according to the ICH code of GCP (cGCP) standards, and IDT has been successfully audited by company and regulatory auditors.

IDT has experience in many therapeutic areas including oncology, HIV/AIDS, cardiovascular, CNS, endocrinology, gastroenterology, immunology, and anti-infectives. In addition, we have established enduring relationships with key opinion leaders in all of these areas.

We can provide the full complement of services, from identifying sites and designing protocols and CRFs, to producing a final integrated report. This means that we can provide some or all of these services, depending upon your requirements, and can work according to our SOPs or yours.

IDT is also licensed to manufacture therapeutic goods for clinical trials, for example, ointments, creams, capsules and tablets.

IDT is the only Australian CRO that can offer the full range of support services, including Pharmacy Services (ie. drug randomisation, labelling and packaging, distribution, accountability); regulatory affairs (ie. preparation of documentation to the TGA and/or ethics committee requesting approval to run clinical trials) and report writing.

E-mail : clinical@idtaus.com.au